Oncology News and Research

RSS
Ifinatamab deruxtecan may benefit patients with recurrent or progressive ES-SCLC

Ifinatamab deruxtecan may benefit patients with recurrent or progressive ES-SCLC

Osimertinib plus chemotherapy offers overall survival advantage for patients with EGFR-mutated advanced NSCLC

Osimertinib plus chemotherapy offers overall survival advantage for patients with EGFR-mutated advanced NSCLC

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

New antibody-drug conjugate iza-bren may offer promising treatment option for EGFR-mutated NSCLC patients

Ivonescimab plus chemotherapy provides survival benefit for difficult-to-treat NSCLC patients

Ivonescimab plus chemotherapy provides survival benefit for difficult-to-treat NSCLC patients

Study validates deep learning model for predicting future lung cancer risk in Black population

Study validates deep learning model for predicting future lung cancer risk in Black population

Older patients eligible for surgery can benefit from lung cancer screening programs

Older patients eligible for surgery can benefit from lung cancer screening programs

Video-assisted thoracoscopic surgery provides improved overall survival compared to open lobectomy

Video-assisted thoracoscopic surgery provides improved overall survival compared to open lobectomy

NYU Langone strengthens world-leading GI cancer program with renowned leaders

NYU Langone strengthens world-leading GI cancer program with renowned leaders

Smoking fuels pancreatic cancer growth through immune suppression

Smoking fuels pancreatic cancer growth through immune suppression

Novel vascularized cancer-on-a-chip model reflects the microenvironment of liver tumors

Novel vascularized cancer-on-a-chip model reflects the microenvironment of liver tumors

Urine test identifies three biomarkers for accurate prostate cancer detection

Urine test identifies three biomarkers for accurate prostate cancer detection

Breakthrough discovery reveals treatable form of familial mesothelioma

Breakthrough discovery reveals treatable form of familial mesothelioma

MicroRNA panels show promise for improving prostate cancer diagnosis

MicroRNA panels show promise for improving prostate cancer diagnosis

Dormant tumor cells targeted to reduce breast cancer relapse

Dormant tumor cells targeted to reduce breast cancer relapse

Study urges significant investment in cancer research in poorer nations

Study urges significant investment in cancer research in poorer nations

Landmark study maps mutational landscape of triple-negative breast cancer in African American women

Landmark study maps mutational landscape of triple-negative breast cancer in African American women

Androgen deprivation therapy lowers satisfaction after penile prosthesis surgery

Androgen deprivation therapy lowers satisfaction after penile prosthesis surgery

Exploring testosterone's influence on cardiovascular, metabolic, reproductive, and mental health

Exploring testosterone's influence on cardiovascular, metabolic, reproductive, and mental health

Study provides evidence for a causal genetic link between prostate cancer and urothelial carcinoma

Study provides evidence for a causal genetic link between prostate cancer and urothelial carcinoma

Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma

Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.